Modified Release Minoxidil Compositions and Methods for Oral Administration
Summary
The USPTO published patent application US20260091035A1 by inventor Reid Waldman covering modified release minoxidil pharmaceutical formulations for oral daily dosing to treat hair loss. The application claims compositions including slow modified release vehicles containing minoxidil or pharmaceutically acceptable salts, optionally combined with additional active agents. Filing date was December 9, 2025.
What changed
The USPTO published patent application US20260091035A1 on April 2, 2026, covering compositions and methods for modified release minoxidil formulations. The application (No. 19414251, filed Dec. 9, 2025) by inventor Reid Waldman discloses pharmaceutical formulations for oral administration comprising a daily dose of modified release minoxidil or salts thereof, methods of treating hair loss, and kits containing slow release vehicles. CPC classifications include A61K 31/506, A61K 9/0053, and related formulation categories.
This is a routine patent application publication providing public notice of pending intellectual property claims. No regulatory action or compliance response is required from pharmaceutical companies, drug manufacturers, or other parties. Parties interested in Freedom to Operate analyses or licensing discussions may wish to review the published claims. Patent applications do not impose regulatory obligations or deadlines on the pharmaceutical industry.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
Application US20260091035A1 Kind: A1 Apr 02, 2026
Inventors
Reid WALDMAN
Abstract
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.
CPC Classifications
A61K 31/506 A61K 9/0053 A61K 9/2013 A61K 9/2018 A61K 9/2054 A61K 9/28 A61P 17/14
Filing Date
2025-12-09
Application No.
19414251
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.